Genetic Variation in IL28B: Impact on Drug Development for Chronic Hepatitis C Infection

被引：8
|
作者：
Clark, P. J. [1 ,2 ]
Thompson, A. J. V. [1 ,2 ]
McHutchison, J. G. [1 ,2 ]
机构：
[1] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Div Gastroenterol, Durham, NC USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 88卷 / 05期
基金：
英国医学研究理事会;
关键词：
INTERFERON-LAMBDA; PEGINTERFERON ALPHA-2A; PLUS RIBAVIRIN; TELAPREVIR; GENOTYPE-1; INHIBITOR; THERAPY; TYPE-1;
D O I：
10.1038/clpt.2010.185
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
As more pharmacogenomic insights into diseases and their treatments and toxicities are published each year, the challenge arises to incorporate such insights into clinical practice and drug development.(1) For instance, recent genomic discoveries related to hepatitis C offer a challenge to clinicians, researchers, and health administrators to translate this information into knowledge in order to develop safer and more effective therapeutic strategies for all patients.
引用
收藏
页码：708 / 711
页数：4
相关论文
共 50 条
  • [21] Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
    Rauch, Andri
    Kutalik, Zoltan
    Descombes, Patrick
    Cai, Tao
    Di Iulio, Julia
    Mueller, Tobias
    Bochud, Murielle
    Battegay, Manuel
    Bernasconi, Enos
    Borovicka, Jan
    Colombo, Sara
    Cerny, Andreas
    Dufour, Jean-Francois
    Furrer, Hansjakob
    Guenthard, Huldrych F.
    Heim, Markus
    Hirschel, Bernard
    Malinverni, Raffaele
    Moradpour, Darius
    Muellhaupt, Beat
    Witteck, Andrea
    Beckmann, Jacques S.
    Berg, Thomas
    Bergmann, Sven
    Negro, Francesco
    Telenti, Amalio
    Bochud, Pierre-Yves
    GASTROENTEROLOGY, 2010, 138 (04) : 1338 - U173
  • [22] Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
    Ge, Dongliang
    Fellay, Jacques
    Thompson, Alexander J.
    Simon, Jason S.
    Shianna, Kevin V.
    Urban, Thomas J.
    Heinzen, Erin L.
    Qiu, Ping
    Bertelsen, Arthur H.
    Muir, Andrew J.
    Sulkowski, Mark
    McHutchison, John G.
    Goldstein, David B.
    NATURE, 2009, 461 (7262) : 399 - 401
  • [23] IL28B GENETIC VARIANTS AND GENDER ARE ASSOCIATED WITH SPONTANEOUS CLEARANCE OF HEPATITIS C VIRUS INFECTION
    Rao, H. Y.
    Sun, D. G.
    Jiang, D.
    Yang, R. F.
    Guo, F.
    Wang, J. H.
    Liu, F.
    Zhang, H. Y.
    Zhang, H. H.
    Du, S. C.
    Lok, A. S.
    Wei, L.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S529 - S529
  • [24] IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection
    Rao, H. -Y.
    Sun, D. -G.
    Jiang, D.
    Yang, R. -F.
    Guo, F.
    Wang, J. -H.
    Liu, F.
    Zhang, H. -Y.
    Zhang, H. -H.
    Du, S. -C.
    Jin, Q.
    Qin, H.
    Lok, A. -S. -F.
    Wei, L.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 (03) : 173 - 181
  • [25] Is there clinical utility to IL28B genotype testing in the treatment of chronic hepatitis C virus infection?
    Liapakis, AnnMarie
    Jesudian, Arun B.
    PHARMACOGENOMICS, 2012, 13 (12) : 1317 - 1319
  • [26] IL28B: A new wager in the skyline of hepatitis C virus infection
    Mangia, Alessandra
    DIGESTIVE AND LIVER DISEASE, 2011, 43 (03) : 177 - 179
  • [27] IL28B Genotyping - A Personalized Approach for Treating Chronic Hepatitis C
    Rallon, Norma I.
    AIDS REVIEWS, 2010, 12 (01) : 62 - 62
  • [28] Genetic Variation in IL28B and Treatment-induced Clearance of Hepatitis C Virus in HIV-Positive Patients With Acute and Chronic Hepatitis C
    Nattermann, Jacob
    Vogel, Martin
    Nischalke, Hans Dieter
    Danta, Mark
    Mauss, Stefan
    Stellbrink, Hans-Joerg
    Baumgarten, Axel
    Mayr, Christoph
    Bruno, Raffaele
    Tural, Cristina
    Klausen, Gerd
    Clotet, Bonaventura
    Naumann, Uwe
    Lutz, Thomas
    Rausch, Michael
    Schewe, Knud
    Bienek, Bernhard
    Haerter, Georg
    Sauerbruch, Tilman
    Rockstroh, Juergen K.
    Spengler, Ulrich
    JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (05): : 595 - 601
  • [29] IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C
    Andrzej Ciela
    Monika Bociaga-Jasik
    Iwona Sobczyk-Krupiarz
    Mikolaj K Glowacki
    Danuta Owczarek
    Dorota Cibor
    Marek Sanak
    Tomasz Mach
    World Journal of Gastroenterology, 2012, (35) : 4892 - 4897
  • [30] Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection
    Joshita, Satoru
    Umemura, Takeji
    Katsuyama, Yoshihiko
    Ichikawa, Yuki
    Kimura, Takefumi
    Morita, Susumu
    Kamijo, Atsushi
    Komatsu, Michiharu
    Ichijo, Tetsuya
    Matsumoto, Akihiro
    Yoshizawa, Kaname
    Kamijo, Nozomi
    Ota, Masao
    Tanaka, Eiji
    HUMAN IMMUNOLOGY, 2012, 73 (03) : 298 - 300
12345